GSK207972: A study looking at a new injectable medication to treat moderate to severe asthma with allergic fungal airway disease

This study is looking at whether a new injectable medication can treat moderate to severe asthma with allergic fungal airway disease.


  • Be diagnosed with moderate to severe asthma
  • Are sensitised to specific types of fungi
  • be a current non smoker and not smoked in the past six months
  • Had at least one severe exacerbation of asthma in the past year that required at least three days of oral (tablets) steroid treatment
  • must have attended clinic at UHSM (Wythenshawe)  within the last 5 years


University Hospital of South Manchester NHS Foundation Trust



  • Being randomly chosen to receive either the new treatment or a placebo
  • Attending 9 clinic visits over 16 weeks and a follow-up visit 12 weeks after the main part of the study.
  • Clinic visits will include having blood and sputum samples taken, electrocardiograms (ECG) and breathing tests. You will also be asked to complete questionnaires about your symptoms.


Recruiting Until

31st March 2019

Want to take part or learn more?

Contact Us

Share this study